Clinical trial
Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network
NCT03657875 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study to Describe Prevalence of Hyperkalemia in Russian Population Based on Large Laboratory Network
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 15, 2017
- Completion date
- September 15, 2017
- Enrollment
- 53,940 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperkalemia elevated plasma k+ cardiovascular disease (cvd)